- Home
- MTVA vs VSEE Comparison
MTVA vs VSEE Comparison
Compare MTVA & VSEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTVA
- VSEE
- Stock Information
- Founded
- MTVA 2014
- VSEE 2008
- Country
- MTVA United States
- VSEE United States
- Employees
- MTVA N/A
- VSEE N/A
- Industry
- MTVA
- VSEE
- Sector
- MTVA
- VSEE
- Exchange
- MTVA NYSE
- VSEE NYSE
- Market Cap
- MTVA 18.9M
- VSEE 21.5M
- IPO Year
- MTVA N/A
- VSEE N/A
- Fundamental
- Price
- MTVA $1.95
- VSEE $1.47
- Analyst Decision
- MTVA Strong Buy
- VSEE
- Analyst Count
- MTVA 1
- VSEE 0
- Target Price
- MTVA $12.00
- VSEE N/A
- AVG Volume (30 Days)
- MTVA 337.7K
- VSEE 534.9K
- Earning Date
- MTVA 11-07-2024
- VSEE 02-15-2025
- Dividend Yield
- MTVA N/A
- VSEE N/A
- EPS Growth
- MTVA N/A
- VSEE N/A
- EPS
- MTVA N/A
- VSEE N/A
- Revenue
- MTVA N/A
- VSEE $8,064,925.00
- Revenue This Year
- MTVA N/A
- VSEE N/A
- Revenue Next Year
- MTVA N/A
- VSEE N/A
- P/E Ratio
- MTVA N/A
- VSEE N/A
- Revenue Growth
- MTVA N/A
- VSEE 37.45
- 52 Week Low
- MTVA $1.51
- VSEE $1.12
- 52 Week High
- MTVA $6.75
- VSEE $33.08
- Technical
- Relative Strength Index (RSI)
- MTVA N/A
- VSEE N/A
- Support Level
- MTVA N/A
- VSEE N/A
- Resistance Level
- MTVA N/A
- VSEE N/A
- Average True Range (ATR)
- MTVA 0.00
- VSEE 0.00
- MACD
- MTVA 0.00
- VSEE 0.00
- Stochastic Oscillator
- MTVA 0.00
- VSEE 0.00
About MTVA METAVIA INC
MetaVia Inc Formerly NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.
About VSEE VSEE HEALTH INC
VSee Health Inc is a telehealth software platform. VSee's telemedicine solution, offering a fast, secure text + video collaboration app HIPAA messenger, and fully customizable virtual waiting rooms and clinics, is a complete telehealth platform that fits into any workflow. The VSee proprietary technology platform and modular software solution enable users to plug and play telehealth services with end-to-end encrypted video streaming integrated with patient metrics, electronic medical records, and other sensitive data, with multiple other interactive functionalities. The company's products include VSee Clinic, VSee Messenger, VSee APIs, VSee Remote patient monitoring, VSee Telehealth Staffing.